On Thursday, December 9, 2021, the Food and Drug Administration (FDA) authorized the use of the Pfizer-BioNTech COVID-19 booster shot among 16- and 17-year-olds.
The booster is authorized for use at least six months after getting the second dose of the two-dose Pfizer-BioNTech vaccine – the only vaccine currently authorized for use among 16- and 17-year-olds.
All U.S. adults have been authorized to receive COVID-19 boosters since November.
Expanding vaccine boosters to 16- and 17-year-olds is intended to help reduce cases of the rapidly spreading coronavirus Omicron variant.
Health experts continue to emphasize the importance of vaccination for those eligible to receive the shots.
Parents of teens eligible for COVID-19 vaccines or boosters should speak with their children’s primary care physicians about vaccination.
Similarly, parents should look for updated guidance from school districts, which may require vaccination for in-person learning in 2022.
The information contained within these materials are confidential and not to be distributed. Use of and access to this information, site, or any of the links contained within this document does not create a relationship between the recipient and CoverEase.